About UCLA - JCCC Dept of OBGYN - Women's Health Clinical Research Unit
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at UCLA - JCCC Dept of OBGYN - Women's Health Clinical Research Unit
During the past decade, UCLA - JCCC Dept of OBGYN - Women's Health Clinical Research Unit conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "UCLA - JCCC Dept of OBGYN - Women's Health Clinical Research Unit"
#1 collaborator was "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator and "Gynecologic Oncology Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at UCLA - JCCC Dept of OBGYN - Women's Health Clinical Research Unit
According to Clinical.Site data, the most researched conditions in "UCLA - JCCC Dept of OBGYN - Women's Health Clinical Research Unit" are
"Fallopian Tube Cancer" (2 trials), "Peritoneal Cancer" (2 trials), "Epithelial Ovarian Cancer" (1 trials) and "Ovarian Cancer" (1 trials). Many other conditions were trialed in "UCLA - JCCC Dept of OBGYN - Women's Health Clinical Research Unit" in a lesser frequency.
Clinical Trials Intervention Types at UCLA - JCCC Dept of OBGYN - Women's Health Clinical Research Unit
Most popular intervention types in "UCLA - JCCC Dept of OBGYN - Women's Health Clinical Research Unit" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Mirvetuximab Soravtansine" (1 trials), "Mirvetuximab soravtansine" (1 trials), "Paclitaxel" (1 trials), "Pegylated liposomal doxorubicin" (1 trials) and "Topotecan" (1 trials). Other intervention names were less common.
Clinical Trials Genders at UCLA - JCCC Dept of OBGYN - Women's Health Clinical Research Unit
The vast majority of trials in "UCLA - JCCC Dept of OBGYN - Women's Health Clinical Research Unit" are
2 trials for "Female" genders.
Clinical Trials Status at UCLA - JCCC Dept of OBGYN - Women's Health Clinical Research Unit
Currently, there are NaN active trials in "UCLA - JCCC Dept of OBGYN - Women's Health Clinical Research Unit".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in UCLA - JCCC Dept of OBGYN - Women's Health Clinical Research Unit,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in UCLA - JCCC Dept of OBGYN - Women's Health Clinical Research Unit, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".